406 related articles for article (PubMed ID: 29705704)
41. Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated
Xiang X; Fu Y; Zhao K; Miao R; Zhang X; Ma X; Liu C; Zhang N; Qu K
Theranostics; 2021; 11(10):4929-4944. PubMed ID: 33754036
[No Abstract] [Full Text] [Related]
42. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
[TBL] [Abstract][Full Text] [Related]
43. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
[TBL] [Abstract][Full Text] [Related]
44. Liver X receptor inhibits the growth of hepatocellular carcinoma cells via regulating HULC/miR-134-5p/FOXM1 axis.
He J; Yang T; He W; Jiang S; Zhong D; Xu Z; Wei Q; Zhang Y; Shi C
Cell Signal; 2020 Oct; 74():109720. PubMed ID: 32711110
[TBL] [Abstract][Full Text] [Related]
45. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.
Liu J; Li J; Wang K; Liu H; Sun J; Zhao X; Yu Y; Qiao Y; Wu Y; Zhang X; Zhang R; Yang A
Signal Transduct Target Ther; 2021 Feb; 6(1):42. PubMed ID: 33526768
[TBL] [Abstract][Full Text] [Related]
46. FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells.
Wuputra K; Hsiao PJ; Chang WT; Wu PH; Chen LA; Huang JW; Su WL; Yang YH; Wu DC; Yokoyama KK; Kuo KK
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887129
[TBL] [Abstract][Full Text] [Related]
47. Autophagic protein ULK1 regulates FOXM1 signalling in human hepatoma cells.
Rajak S; Raza S; Tewari A; Yadav S; Ghosh S; Yen PM; Sinha RA
Biochem Biophys Res Commun; 2020 Nov; 532(4):570-575. PubMed ID: 32900486
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer.
Liu A; Zeng S; Lu X; Xiong Q; Xue Y; Tong L; Xu W; Sun Y; Zhang Z; Xu C
Int J Biol Macromol; 2019 Feb; 123():322-334. PubMed ID: 30414902
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
50. The Forkhead box transcription factor FOXM1 is required for the maintenance of cell proliferation and protection against oxidative stress in human embryonic stem cells.
Kwok CT; Leung MH; Qin J; Qin Y; Wang J; Lee YL; Yao KM
Stem Cell Res; 2016 May; 16(3):651-61. PubMed ID: 27062359
[TBL] [Abstract][Full Text] [Related]
51. Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth.
Chen T; Xiong J; Yang C; Shan L; Tan G; Yu L; Tan Y
Cancer Gene Ther; 2014 Mar; 21(3):133-8. PubMed ID: 24577129
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of
Bai L; Ren Y; Cui T
J Comput Biol; 2020 Jun; 27(6):965-974. PubMed ID: 31593490
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of Forkhead box M1 protein associates with aggressive tumor features and poor prognosis of hepatocellular carcinoma.
Sun HC; Li M; Lu JL; Yan DW; Zhou CZ; Fan JW; Qin XB; Tang HM; Peng ZH
Oncol Rep; 2011 Jun; 25(6):1533-9. PubMed ID: 21431285
[TBL] [Abstract][Full Text] [Related]
54. High expression of FOXM1 critical for sustaining cell proliferation in mitochondrial DNA-less liver cancer cells.
Higurashi M; Maruyama T; Nogami Y; Ishikawa F; Yoshida Y; Mori K; Fujita KI; Shibanuma M
Exp Cell Res; 2020 Apr; 389(1):111889. PubMed ID: 32032602
[TBL] [Abstract][Full Text] [Related]
55. CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma.
Zou Y; Ruan S; Jin L; Chen Z; Han H; Zhang Y; Jian Z; Lin Y; Shi N; Jin H
Med Sci Monit; 2020 Aug; 26():e925289. PubMed ID: 32863381
[TBL] [Abstract][Full Text] [Related]
56. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
57. Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1-FOXO1 axis.
Chand V; Liao X; Guzman G; Benevolenskaya E; Raychaudhuri P
Oncogene; 2022 Jul; 41(30):3778-3790. PubMed ID: 35761036
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
[TBL] [Abstract][Full Text] [Related]
59. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma.
Xu Z; Pei C; Cheng H; Song K; Yang J; Li Y; He Y; Liang W; Liu B; Tan W; Li X; Pan X; Meng L
Front Immunol; 2023; 14():1138524. PubMed ID: 37234166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
